术前他汀使用对下肢外周动脉血管成形术患者主要通畅率和截肢的影响
这项回顾性队列研究纳入178例因严重肢体缺血或限制性跛行接受下肢经皮腔内血管成形术的患者,按住院前及住院期间是否使用他汀分组,比较人口学、病变形态、主要通畅率和保肢率。结果显示术前他汀使用与主要通畅率改善无关(P=0.2798),校正变量后主要通畅率(HR 0.87 [0.33-2.29],P=0.79)和截肢(HR 0.70 [0.40-1.23],P=0.22)均无统计学显著差异。
要点
- 术前他汀使用与下肢血管成形术后主要通畅率改善无关(P=0.2798)。
- 校正变量后主要通畅率HR 0.87(0.33-2.29),P=0.79,无统计学显著差异。
- 校正变量后截肢HR 0.70(0.40-1.23),P=0.22,无统计学显著差异。
核心结论
- 术前他汀使用未改善下肢外周动脉血管成形术患者的主要通畅率或截肢率。
研究设计与样本
- 回顾性队列研究,纳入178例因下肢严重缺血或限制性跛行接受下肢经皮腔内血管成形术的患者,按住院前及住院期间是否使用他汀分组,比较人口学、病变形态、主要通畅率和保肢率,采用Kaplan-Meier和多因素回归分析。
主要发现
- 约80%的手术为球囊血管成形术,1年主要通畅率为73%。
- 术前他汀使用与主要通畅率改善无关(P=0.2798)。
- 校正住院前他汀使用、糖尿病、手术指征、病变位置、Trans-Atlantic Inter-Society Consensus分类和当前吸烟等变量后,术前他汀使用与主要通畅率(HR 0.87 [0.33-2.29],P=0.79)或截肢(HR 0.70 [0.40-1.23],P=0.22)均无统计学显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral arterial disease can progress to critical limb ischemia, which is associated with high amputation rates and requires revascularization. The endovascular approach has lower long-term patency because of restenosis due to neointimal hyperplasia. Statins are significantly advantageous for patients undergoing percutaneous interventions; however, only few studies have reported surgical improvements with statin therapy after endovascular treatment in such patients. This retrospective cohort study assessed the effects of preprocedural statins on lower limb arterial angioplasty outcomes by evaluating patency and amputation rates and comparing with those without statins. METHODS: Patients who underwent percutaneous transluminal angioplasty of the lower limbs for critical ischemia of the lower limbs or for limiting claudication were included in this retrospective cohort study. Patients were categorized according to statin use prior to and during hospitalization. Patient demographics, lesion morphology, primary patency, and limb salvage rates were compared between these groups. Statistical analyses were performed using Kaplan-Meier and multivariate regression analysis. RESULTS: A total of 178 patients undergoing endovascular intervention by critical ischemia or limiting claudication were included. Approximately 80% of the procedures were ballon angioplasty. Primary patency was 73% in 1 year and preprocedural statin usage was not associated with improved primary patency rates (P = 0.2798). After adjusting the amputation outcomes for pre-established variables, such as prehospitalization statin use, diabetes, procedure indication, disease location, Trans-Atlantic Inter-Society Consensus classification, and current smoking, there was no statistically significant difference associated with preprocedural statin use in primary patency (hazard ratio: 0.87 [0.33-2.29], P = 0.79) or amputation (hazard ratio: 0.70 [0.40-1.23], P = 0.22). CONCLUSIONS: The use of preprocedural statin did not improve primary patency or amputation rates in patients undergoing peripheral angioplasty.
引用
- Braun SK, Jorge DW, Pedron VF, et al. Influence of Preprocedural Statin Usage on Primary Patency and Amputation in Patients Undergoing Lower Limb Peripheral Angioplasty. Ann Vasc Surg. 2024. PMID: 38821472. doi:10.1016/j.avsg.2024.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。